Search people, articles, bills, and more
Alzheimer's disease is a growing global health and economic crisis, projected to affect over 150 million people worldwide by 2050 and cost trillions. This bill matters because it proposes a proactive step for the U.S. to join a concerted international effort to tackle this disease, rather than relying solely on domestic initiatives. By formally participating in the Davos Alzheimer's Collaborative, the U.S. would pool resources, knowledge, and scientific expertise with other nations and private entities, potentially speeding up the discovery of new ways to prevent, diagnose, and treat Alzheimer's.
If this bill becomes law, the U.S. would have a voice in a leading global initiative, sharing the financial burden and potentially bringing effective solutions to patients faster, both in the U.S. and around the world, including disproportionately affected minority populations. If it doesn't pass, the U.S. would not officially participate in this specific collaborative, potentially slowing down advancements that could come from shared international efforts.
No reactions yet. Be the first to weigh in.
Alzheimer's disease is a growing global health and economic crisis, projected to affect over 150 million people worldwide by 2050 and cost trillions. This bill matters because it proposes a proactive step for the U.S. to join a concerted international effort to tackle this disease, rather than relying solely on domestic initiatives. By formally participating in the Davos Alzheimer's Collaborative, the U.S. would pool resources, knowledge, and scientific expertise with other nations and private entities, potentially speeding up the discovery of new ways to prevent, diagnose, and treat Alzheimer's.
If this bill becomes law, the U.S. would have a voice in a leading global initiative, sharing the financial burden and potentially bringing effective solutions to patients faster, both in the U.S. and around the world, including disproportionately affected minority populations. If it doesn't pass, the U.S. would not officially participate in this specific collaborative, potentially slowing down advancements that could come from shared international efforts.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
| AMOUNT | PROGRAM | TYPE | YEARS |
|---|---|---|---|
| Amounts authorized to be appropriated and made available to carry out chapters 1 and 10 of part I and chapter 4 of part II of the Foreign Assistance Act of 1961 (22 U.S.C. 2151 et seq.) | United States contributions to the Davos Alzheimer's Collaborative (DAC) | discretionary | fiscal years 2026 through 2030 (for the matching requirement) |